| Product NDC: | 0004-0261 | 
| Proprietary Name: | CellCept | 
| Non Proprietary Name: | Mycophenolate Mofetil | 
| Active Ingredient(s): | 200 mg/mL & nbsp; Mycophenolate Mofetil | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | POWDER, FOR SUSPENSION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0004-0261 | 
| Labeler Name: | Genentech, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA050759 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 19980812 | 
| Package NDC: | 0004-0261-29 | 
| Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (0004-0261-29) > 225 mL in 1 BOTTLE, PLASTIC | 
| NDC Code | 0004-0261-29 | 
| Proprietary Name | CellCept | 
| Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (0004-0261-29) > 225 mL in 1 BOTTLE, PLASTIC | 
| Product NDC | 0004-0261 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Mycophenolate Mofetil | 
| Dosage Form Name | POWDER, FOR SUSPENSION | 
| Route Name | ORAL | 
| Start Marketing Date | 19980812 | 
| Marketing Category Name | NDA | 
| Labeler Name | Genentech, Inc. | 
| Substance Name | MYCOPHENOLATE MOFETIL | 
| Strength Number | 200 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | Antimetabolite Immunosuppressant [EPC] |